Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02606721 · ClinicalTrials.gov registry record
Food Allergy Challenge Diagnostic Study
A clinical trial, sponsored by ORA.
- Completed
- Registry status
- 6
- Enrollment target
NCT02606721 is a clinical trial that has completed, run by ORA. The registered enrollment target is 6 participants.
The verdict
NCT02606721 has completed, sponsored by ORA.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemic reaction occurs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02606721
The ClinicalTrials.gov registry entry for NCT02606721 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ORA, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02606721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02606721 about?
NCT02606721 is a clinical study titled "Food Allergy Challenge Diagnostic Study". The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemi...
What is the current status of trial NCT02606721?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2016-03. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02606721?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.